National Pension Service
BMRN icon

National Pension Service’s BioMarin Pharmaceuticals BMRN Stock Holding History

National Pension Service’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,412
Closed -$1.11M – 565
2025
Q3 		$1.11M Buy
20,412
+6,534
+47% +$374K ﹤0.01% 490
2025
Q2 		$763K Hold
13,878
– – ﹤0.01% 484
2025
Q1 		$981K Hold
13,878
– – ﹤0.01% 478
2024
Q4 		$912K Sell
13,878
-331,509
-96% -$22.2M ﹤0.01% 512
2024
Q3 		$24.3M Buy
345,387
+13,878
+4% +$1.16M 0.02% 478
2024
Q2 		$27.3M Buy
331,509
+20,921
+7% +$1.74M 0.03% 450
2024
Q1 		$27.1M Buy
310,588
+17,286
+6% +$1.55M 0.03% 451
2023
Q4 		$28.3M Hold
293,302
– – 0.04% 393
2023
Q3 		$25.8M Buy
293,302
+2,534
+0.9% +$225K 0.04% 390
2023
Q2 		$25.9M Buy
290,768
+23,486
+9% +$2.21M 0.04% 409
2023
Q1 		$25.5M Hold
267,282
– – 0.05% 377
2022
Q4 		$27.7M Sell
267,282
-12,141
-4% -$1.14M 0.05% 359
2022
Q3 		$23.8M Sell
279,423
-28,883
-9% -$2.57M 0.05% 375
2022
Q2 		$25.5M Hold
308,306
– – 0.05% 374
2022
Q1 		$23.8M Buy
+308,306
New +$25.8M 0.04% 446
2021
Q4 		– Sell
-303,532
Closed -$23.5M – 520
2021
Q3 		$23.5M Sell
303,532
-2,947
-1% -$233K 0.04% 427
2021
Q2 		$25.6M Hold
306,479
– – 0.05% 435
2021
Q1 		$23.1M Buy
306,479
+4,511
+1% +$368K 0.05% 440
2020
Q4 		$26.5M Buy
301,968
+48,244
+19% +$3.82M 0.06% 374
2020
Q3 		$19.8M Hold
253,724
– – 0.05% 399
2020
Q2 		$31.3M Sell
253,724
-39,593
-13% -$3.94M 0.09% 248
2020
Q1 		$24.8M Hold
293,317
– – 0.08% 272
2019
Q4 		$24.8M Buy
293,317
+60,255
+26% +$4.55M 0.07% 354
2019
Q3 		$15.7M Buy
233,062
+12,168
+6% +$937K 0.05% 401
2019
Q2 		$18.9M Buy
220,894
+13,432
+6% +$1.15M 0.06% 375
2019
Q1 		$18.4M Buy
207,462
+8,556
+4% +$793K 0.07% 333
2018
Q4 		$18.6M Buy
198,906
+8,918
+5% +$848K 0.08% 315
2018
Q3 		$18.4M Hold
189,988
– – 0.08% 310
2018
Q2 		$17.3M Sell
189,988
-1,343
-0.7% -$118K 0.08% 317
2018
Q1 		$15.5M Buy
191,331
+13,236
+7% +$1.14M 0.08% 351
2017
Q4 		$15.9M Buy
178,095
+9,772
+6% +$850K 0.08% 333
2017
Q3 		$15.6M Buy
168,323
+6,464
+4% +$571K 0.09% 293
2017
Q2 		$14.6M Buy
161,859
+14,386
+10% +$1.31M 0.09% 299
2017
Q1 		$13.1M Buy
147,473
+11,552
+8% +$1.03M 0.09% 300
2016
Q4 		$11.3M Buy
135,921
+8,812
+7% +$758K 0.08% 342
2016
Q3 		$11.8M Buy
127,109
+10,832
+9% +$1.02M 0.09% 279
2016
Q2 		$9.05M Buy
116,277
+24,135
+26% +$2.05M 0.08% 329
2016
Q1 		$7.6M Buy
92,142
+3,729
+4% +$303K 0.08% 331
2015
Q4 		$9.26M Buy
88,413
+3,660
+4% +$382K 0.1% 263
2015
Q3 		$8.93M Buy
84,753
+12,239
+17% +$1.63M 0.11% 236
2015
Q2 		$9.92M Buy
72,514
+11,231
+18% +$1.39M 0.13% 207
2015
Q1 		$7.64M Buy
61,283
+9,019
+17% +$956K 0.11% 248
2014
Q4 		$4.72M Sell
52,264
-5,940
-10% -$494K 0.08% 313
2014
Q3 		$4.2M Buy
+58,204
New +$3.83M 0.07% 370

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

National Pension Service's BMRN Position: Q4 2025 in Review

National Pension Service sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2025, closing a stake of 20,412 shares — an estimated $1.11M sold.

National Pension Service first reported a position in BMRN in Q3 2014 and held it in 44 quarters. The position peaked at $31.3M in Q2 2020. 539 funds tracked by Wall St. Rank hold BMRN as of Q4 2025.

  • National Pension Service reported no remaining BioMarin Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • National Pension Service sold 20,412 BioMarin Pharmaceuticals shares in Q4 2025, an estimated $1.11M.
  • National Pension Service first reported a position in BioMarin Pharmaceuticals in Q3 2014 and held it in 44 quarters.
  • National Pension Service's BioMarin Pharmaceuticals position peaked at $31.3M in Q2 2020.
  • 539 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2025.

Based on National Pension Service's 13F filing for Q4 2025, filed 10 Feb 2026.